HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

718.609

+2.6430.37%

Number of Gainers:14

Number of Losers:17

Number of Flat:3

PE:- -

High:728.504

Open:715.966

Low:704.159

Close:715.966

Volume:89.31M

Turnover:3.25B

Market Cap:460.13B

Float Cap:408.40B

Loading ...

Taishan District Market Supervision Bureau in Shandong Conducts Oversight Inspection on Class I Medical Device (Protective Gear) Manufacturers

ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials

CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase

Appeal Hearing Concludes for Hainan Poly Pharm Investor Compensation Case, Beijing Tongtech Claim Filed Again

EDDING GENOR Repurchases Shares Worth HK$1.75 Million

Policy Tailwinds Propel Huabao Fund's Hong Kong Connect Biotech and Healthcare ETFs to Consecutive Gains

ZYLOXTB (02190) Repurchases 48,000 Shares for HK$1.1454 Million on April 16

AI Drug Discovery Firm Valued at $1 Billion Following Funding Round, Attracts Investment from Pharma Giants

BRII-B Files Arbitration Claim Against Vir Biotechnology with US Mediation Service

Brii Biosciences Ltd - Seeks Transfer of Elebsiran Manufacturing and Damages From Vir for Alleged Breach

THOMSON REUTERS

Brii Biosciences Ltd - Submits Demand for Arbitration Against Vir on April 16, 2026

THOMSON REUTERS

Brii Biosciences files arbitration demand against Vir over elebsiran manufacturing transfer

TYK MEDICINES-B's (02410) Self-Developed TY-3002 Monotherapy Demonstrates Outstanding Weight Loss Efficacy, Pioneering Next-Generation Oral GLP-1R Small Molecule Innovation

Hetero Pharma Aims for Global Sales Target of 1.5 Million Semaglutide Pens Annually

Hua Medicine proposes bylaw changes to allow electronic, hybrid shareholder meetings

Harbour Biomed Appoints DR. Adam Zong as President

THOMSON REUTERS

Press Release: Harbour BioMed Appoints Dr. Adam Zong as President

Platform-Based Medical Device Firms Show Steady Growth; Domestic IVD Leaders Present Turnaround Opportunities

China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development

Foreign Enterprise in Shanghai Donates 190 Boxes of Supplies to Support Seniors and Children

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":718.6086,"timestamp":1776410835656,"preClose":715.96594,"halted":0,"volume":89310618,"delay":0,"changeRate":0.003691,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":2.642639,"latestTime":"04-17 15:27:15","open":715.96594,"high":728.5041,"low":704.15936,"amount":3246623699,"amplitude":0.034003,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776413400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"pbRate":5.627353,"peRate":-94.073273,"turnoverRate":0.003255,"increases":14,"decrements":17,"flats":2,"marketCap":460131019840,"floatMarketCap":408400726224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":728.5041,"amplitude":0.034003,"preClose":715.96594,"low":704.15936,"pbRate":"5.627353","latestPrice":718.6086,"volume":89310618,"delay":0,"open":715.96594,"prevYearClose":556.26263,"prevWeekClose":666.249,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":666.249,"twentyDayClose":575.488,"sixtyDayClose":612.872,"secType":"PLATE","market":"HK","turnoverRate":0.003255,"peRate":-94.073273,"marketCap":460131019840,"floatMarketCap":408400726224,"timestamp":1776410835656,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":14,"down":17,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1154349356","title":"Taishan District Market Supervision Bureau in Shandong Conducts Oversight Inspection on Class I Medical Device (Protective Gear) Manufacturers","url":"https://stock-news.laohu8.com/highlight/detail?id=1154349356","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154349356?lang=en_us&edition=fundamental","pubTime":"2026-04-17 15:02","pubTimestamp":1776409324,"startTime":"0","endTime":"0","summary":"Recently, the Market Supervision Bureau of Taishan District in Tai'an City, Shandong Province, carried out supervisory inspections targeting manufacturers of Class I medical devices, specifically...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","09996","159883","09997","BK1222","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195869971","title":"ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1195869971","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195869971?lang=en_us&edition=fundamental","pubTime":"2026-04-17 14:34","pubTimestamp":1776407662,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) rose nearly 5% in afternoon trading, reaching a high of HK$18.68, close to its historical peak of HK$18.75. At the time of writing, the stock was up 4.73% to HK$18.6, with a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","BK1191","BK4585","BK1574","BK4144","BK4590","01672","GLP","BK1515","BK4588","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175510092","title":"CXO Concept Stocks Lead Declines in Hong Kong Market as Overseas Investment Environment Enters Volatile Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1175510092","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175510092?lang=en_us&edition=fundamental","pubTime":"2026-04-17 11:36","pubTimestamp":1776396983,"startTime":"0","endTime":"0","summary":"CXO concept stocks led the decline in the Hong Kong market. As of the time of writing, JOINN (06127) fell 5.82% to HKD 21.7; PHARMARON (03759) dropped 3.65% to HKD 21.1; and TIGERMED (03347)...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","AGIX","BK1141","BK1576","BK4588","VXUS","CHAT","ARTY","BK1583","01477","AIPO","CXO","BK1574","03759","06127","BK4585","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150357071","title":"Appeal Hearing Concludes for Hainan Poly Pharm Investor Compensation Case, Beijing Tongtech Claim Filed Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1150357071","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150357071?lang=en_us&edition=fundamental","pubTime":"2026-04-17 11:11","pubTimestamp":1776395499,"startTime":"0","endTime":"0","summary":"The appeal hearing for the investor compensation case against Hainan Poly Pharm.Co.,Ltd. (300630), represented by lawyer Xu Feng from Shanghai Jiucheng Law Firm, has concluded at the Hainan...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01477","BK1574","BK0043","300379","BK0231","300630","BK0239","BK0028","BK0132","BK0030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144000452","title":"EDDING GENOR Repurchases Shares Worth HK$1.75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1144000452","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144000452?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:58","pubTimestamp":1776344303,"startTime":"0","endTime":"0","summary":"On April 16, 2026, EDDING GENOR (06998) executed a share repurchase, buying back 545,500 shares at a total cost of approximately HK$1.75 million.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1583","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166006545","title":"Policy Tailwinds Propel Huabao Fund's Hong Kong Connect Biotech and Healthcare ETFs to Consecutive Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1166006545","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166006545?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:51","pubTimestamp":1776340267,"startTime":"0","endTime":"0","summary":"A basket of favorable policies continues to gain momentum. On April 16, Hong Kong-listed pharmaceutical assets remained active, with the Hong Kong Connect Innovative Drug ETF Huabao (520880), which...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199189906","title":"ZYLOXTB (02190) Repurchases 48,000 Shares for HK$1.1454 Million on April 16","url":"https://stock-news.laohu8.com/highlight/detail?id=1199189906","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199189906?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:42","pubTimestamp":1776339779,"startTime":"0","endTime":"0","summary":"On April 16, ZYLONXTB (02190) announced a share repurchase transaction. The company bought back 48,000 of its own shares at a total cost of HK$1.1454 million. The repurchase price per share ranged between HK$23.6 and HK$24.24.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","02190","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107412890","title":"AI Drug Discovery Firm Valued at $1 Billion Following Funding Round, Attracts Investment from Pharma Giants","url":"https://stock-news.laohu8.com/highlight/detail?id=1107412890","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107412890?lang=en_us&edition=fundamental","pubTime":"2026-04-16 18:23","pubTimestamp":1776334990,"startTime":"0","endTime":"0","summary":"The AI-driven pharmaceutical sector has secured another major investment. Recently, Boston-based Alloy Therapeutics announced the completion of a $40 million Series E financing round. This latest...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013999.USD","SG9999002232.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999001176.SGD","LU1894683348.USD","SG9999011175.SGD","BK4533","BK4568","IE00BBT3K403.USD","SG9999001176.USD","LU0225284248.USD","LU1057294990.SGD","BK1191","IE00BLSP4239.USD","SG9999002224.SGD","LU0321505439.SGD","BK4550","LU0306807586.USD","LU0234572021.USD","LU0058720904.USD","LU0225771236.USD","SGXZ57979304.SGD","BK4534","LU1883839398.USD","IE00B19Z3581.USD","BK4599","BK4585","LU1066053197.SGD","SNY","LU0456855351.SGD","LU0306806265.USD","IE00BLSP4452.SGD","BK4588","BK4581","LU0868494617.USD","PFE","LU1894683264.USD","BK1574","LU0321505868.SGD","LU0122379950.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU0289739699.SGD","LU1066051498.USD","SG9999003800.SGD","LU0170899867.USD","LU0985481810.HKD","BK4592","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135733783","title":"BRII-B Files Arbitration Claim Against Vir Biotechnology with US Mediation Service","url":"https://stock-news.laohu8.com/highlight/detail?id=1135733783","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135733783?lang=en_us&edition=fundamental","pubTime":"2026-04-16 17:38","pubTimestamp":1776332305,"startTime":"0","endTime":"0","summary":"BRII-B (02137) has announced that on April 16, 2026, it submitted an arbitration claim against Vir Biotechnology, Inc. to Judicial Arbitration and Mediation Services, Inc. in the United States. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137","BK1161","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627950962","title":"Brii Biosciences Ltd - Seeks Transfer of Elebsiran Manufacturing and Damages From Vir for Alleged Breach","url":"https://stock-news.laohu8.com/highlight/detail?id=2627950962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627950962?lang=en_us&edition=fundamental","pubTime":"2026-04-16 17:30","pubTimestamp":1776331837,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Y12V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02137","BK1587","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627295059","title":"Brii Biosciences Ltd - Submits Demand for Arbitration Against Vir on April 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627295059","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627295059?lang=en_us&edition=fundamental","pubTime":"2026-04-16 17:30","pubTimestamp":1776331837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Y12V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1161","BK1574","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627046295","title":"Brii Biosciences files arbitration demand against Vir over elebsiran manufacturing transfer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627046295","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627046295?lang=en_us&edition=fundamental","pubTime":"2026-04-16 17:30","pubTimestamp":1776331822,"startTime":"0","endTime":"0","summary":"Brii Biosciences filed arbitration demand on April 16, 2026 against Vir Biotechnology at US-based JAMS over disputes tied to elebsiran manufacturing transfer.Claims allege Vir breached 2018 collaboration agreement plus December 19, 2024 Sixth Letter Agreement covering transfer of drug product formulation manufacturing responsibility to Brii.Relief sought includes order for specific performance to transfer elebsiran manufacturing to Brii or its contractors.Damages claim seeks recovery for losses to date, including alleged lost profits plus amounts invested in collaboration.Brii said it cannot yet predict outcome or quantify financial impact because proceedings are at an early stage.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brii Bi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL8GJl71:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4568","BK1574","BK1161","BK1587","VIR","BK4139","BK4585","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181264075","title":"TYK MEDICINES-B's (02410) Self-Developed TY-3002 Monotherapy Demonstrates Outstanding Weight Loss Efficacy, Pioneering Next-Generation Oral GLP-1R Small Molecule Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=1181264075","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181264075?lang=en_us&edition=fundamental","pubTime":"2026-04-16 17:13","pubTimestamp":1776330825,"startTime":"0","endTime":"0","summary":"The weight loss sector, a core focus in global innovative drug development, continues to attract leading industry players. Recently, TYK MEDICINES-B (02410) announced the formal nomination of its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TY","BK1161","BK1574","BK4144","GLP","02410","BK1515","09939","BK4590","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102403805","title":"Hetero Pharma Aims for Global Sales Target of 1.5 Million Semaglutide Pens Annually","url":"https://stock-news.laohu8.com/highlight/detail?id=1102403805","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102403805?lang=en_us&edition=fundamental","pubTime":"2026-04-16 16:51","pubTimestamp":1776329470,"startTime":"0","endTime":"0","summary":"Novo Nordisk's stock price rose by 3.79%. An executive from Hetero Labs, one of India's major private pharmaceutical companies, stated that the firm plans to launch generic versions of weight-loss...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","BK1574","MNDmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627986042","title":"Hua Medicine proposes bylaw changes to allow electronic, hybrid shareholder meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2627986042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627986042?lang=en_us&edition=fundamental","pubTime":"2026-04-16 16:31","pubTimestamp":1776328289,"startTime":"0","endTime":"0","summary":"Hua Medicine proposed amendments to its memorandum and articles of association to permit electronic-only or hybrid general meetings.Changes would also allow shareholder voting by electronic means.Adoption requires shareholder passage of a special resolution at annual general meeting.Revised articles would take effect upon shareholder approval at AGM.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hua Medicine published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL2CKtQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02552","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627262919","title":"Harbour Biomed Appoints DR. Adam Zong as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2627262919","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627262919?lang=en_us&edition=fundamental","pubTime":"2026-04-16 15:20","pubTimestamp":1776324024,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUA45GX1G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","02142","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627186262","title":"Press Release: Harbour BioMed Appoints Dr. Adam Zong as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2627186262","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627186262?lang=en_us&edition=fundamental","pubTime":"2026-04-16 15:20","pubTimestamp":1776324000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, April 16, 2026 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced the appointment of Dr. Adam Zong as President. Dr. Zong will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and Chief Executive Officer of Harbour BioMed.Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed, commented: \"We are very pleased to welcome Dr. Adam Zong to our executive team. His extensive leadership experience across global biopharma organizations and his strong track record in portfolio strategy and business development will be valuable as we continue to advance our innovative pipeline. We look forward to working with him to further strengthen our portfolio and enhance our global partnership.\". Harbour BioMed  is a global biopharmaceutical company committed to the d","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK1583","BK1574","02142","R","BK1161","BK4604","BK4022","BK4585","03160","BK4099","BK4588","BK4232","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117921106","title":"Platform-Based Medical Device Firms Show Steady Growth; Domestic IVD Leaders Present Turnaround Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1117921106","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117921106?lang=en_us&edition=fundamental","pubTime":"2026-04-16 15:03","pubTimestamp":1776323028,"startTime":"0","endTime":"0","summary":"Huachuang Securities released a research report stating that a platform-based business system spanning multiple sectors and regions is the ideal model for leading medical device companies to maintain...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1222","09997","BK1574","BK1100","159883","161027","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124678664","title":"China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1124678664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124678664?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:39","pubTimestamp":1776321543,"startTime":"0","endTime":"0","summary":"China International Capital Corporation (CICC) has released a research report stating that on April 14th, the General Office of the State Council issued the \"Several Opinions on Improving the Drug...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1770034418.SGD","LU2328871848.SGD","01276","06990","BK1588","LU2778985437.USD","LU0417516902.SGD","LU1720050803.USD","LU0502904849.HKD","BK1161","IE00B5MMRT66.SGD","LU2476274308.USD","LU2097828474.EUR","LU0359201885.HKD","BK1589","LU0348784397.USD","LU0348766576.USD","LU1251922891.USD","LU2097828714.EUR","BK1191","IPOS","IE00BPRC5H50.USD","LU0348735423.USD","LU0634319403.HKD","06160","LU0348827113.USD","159992","LU2097828805.USD","IE00B543WZ88.USD","LU0359202008.SGD","09926","LU0307460666.USD","LU2488822045.USD","LU0196878994.USD","LU0455707207.USD","LU0359201612.USD","06978","HK0000252152.HKD","LU1303224171.USD","LU0588546209.SGD","LU2097828557.USD","LU2097828631.EUR","LU0348767384.USD","LU0540923850.HKD","01801","BK1500","HK0000500386.USD","09606","LU1969619763.USD","BK1583","LU1023057109.AUD","BK1574","LU0561508036.HKD","LU2242644610.SGD","LU2399975544.HKD","LU2543165471.USD","LU1719994722.HKD","HK0000252160.HKD","LU0348825331.USD","LU2476274720.SGD","LU1794554557.SGD","HK0000165453.HKD","LU1961090484.USD","LU0417516738.SGD","LU0348783233.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124027396","title":"Foreign Enterprise in Shanghai Donates 190 Boxes of Supplies to Support Seniors and Children","url":"https://stock-news.laohu8.com/highlight/detail?id=1124027396","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124027396?lang=en_us&edition=fundamental","pubTime":"2026-04-16 13:01","pubTimestamp":1776315684,"startTime":"0","endTime":"0","summary":"To fulfill its commitment to \"creating wonderful lives,\" Kobayashi Pharmaceutical (China) recently engaged in a public welfare initiative to give back to the community. Kobayashi Pharmaceutical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":190,"code":"91000000","status":"200"}]}}